Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed CFO
Quarterly results
Director comp.
Credit agrmnt [a]
CC transcript
Inv. presentation
Appointed director

QUIDEL CORP (QDEL) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/01/2019 GN Consolidated Research: 2019 Summary Expectations for Micron Technology, Quidel, Ligand Pharmaceuticals, Altra Industrial Motion, USG, and Equity Lifestyle Properties — Fundamental Analysis, Key Performance Indications
12/17/2018 GN Analysis: Positioning to Benefit within Quidel, Granite Construction, FireEye, Consolidated Edison, EnPro Industries, and Blueprint Medicines — Research Highlights Growth, Revenue, and Consolidated Results
05/08/2018 BW Quidel Reports First Quarter 2018 Financial Results
04/23/2018 BW Quidel to Hold First Quarter 2018 Financial Results Conference Call on May 8, 2018
04/18/2018 GN New Research Coverage Highlights Quidel, Eros International, Hennessy Capital Acquisition Corp. II, United Dominion Realty Trust, Fidus Investment, and Kadant — Consolidated Revenues, Company Growth, and Expectations for 2018
03/27/2018 BW Quidel to Host 2018 Analyst and Investor Day in Chicago
02/26/2018 BW Quidel to Present at Upcoming Conferences
02/21/2018 BW Quidel Reports Fourth Quarter and Full Year 2017 Financial Results
02/07/2018 BW Quidel to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on February 21, 2018
12/21/2017 BW Quidel to Present at 36th Annual J.P. Morgan Healthcare Conference
12/19/2017 BW Quidel Files Form 8-K/A, Reports Historical and Pro Forma Financial Information for Acquired Triage Assets and Combined Quidel and Triage Businesses
12/13/2017 BW Quidel Announces Timing of Filing of Form 8-K/A To Report Historical and Pro Forma Financial Information for Acquired Triage Assets and Combined Quidel and Triage Businesses
11/01/2017 BW Quidel Reports Third Quarter 2017 Financial Results
10/13/2017 BW Quidel to Hold Third Quarter 2017 Financial Results Conference Call on November 1, 2017
09/18/2017 BW Quidel Announces Revised Agreement for Its Pending Acquisition of Alere's B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter Analyzers
07/26/2017 BW Quidel Reports Second Quarter 2017 Financial Results
07/17/2017 BW Quidel Announces Definitive Agreement to Acquire Alere Triage® Assets
07/14/2017 BW Quidel to Hold Second Quarter 2017 Financial Results Conference Call on July 26, 2017
02/24/2011 BW Quidel Reports Fourth Quarter and Full Year 2010 Results
10/27/2010 BW Quidel Reports Third Quarter 2010 Results
10/13/2010 BW Quidel to Hold Third Quarter 2010 Results Conference Call on October 27, 2010
09/29/2010 BW Quidel Announces FDA Clearance of Its QuickVue® RSV 10 Immunoassay Diagnostic Test
08/31/2010 BW Quidel Announces FDA Clearance of Its RapidVue® hCG Pregnancy Lateral Flow Diagnostic Test
07/30/2010 BW Quidel to Present at Wedbush Life Sciences Best Ideas Management Access Conference
07/29/2010 BW Quidel Reports Second Quarter 2010 Results
07/26/2010 BW Quidel Announces the Availability of Its QuickVue®+ Infectious Mononucleosis Lateral Flow Diagnostic Test
07/08/2010 BW Quidel to Hold Second Quarter 2010 Results Conference Call on July 29, 2010
04/29/2010 BW Quidel Reports First Quarter 2010 Results
04/15/2010 BW Quidel to Hold First Quarter 2010 Results Conference Call on April 29, 2010

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy